Regeneron Pharmaceuticals
REGN
#256
Rank
A$120.47 B
Marketcap
$1,096
Share price
-0.56%
Change (1 day)
-24.54%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $60.01. In 2022 the company made an earnings per share (EPS) of $65.09 a decrease over its 2021 EPS that were of $122.80.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-13.6%
2022$65.09-47%
2021$122.80133.36%
2020$52.6269.13%
2019$31.11-14.44%
2018$36.37100.71%
2017$18.1231.78%
2016$13.7538.96%
2015$9.8972.55%
2014$5.73-17.55%
2013$6.96-44.98%
2012$12.64-422.54%
2011-$3.9292.13%
2010-$2.0449.41%
2009-$1.37-15.84%
2008-$1.62-36.88%
2007-$2.57-9.6%
2006-$2.844.12%
2005-$2.73-323.68%
2004$1.22-135.51%
2003-$3.44-24.38%
2002-$4.5556.35%
2001-$2.91187.3%
2000-$1.01-16%
1999-$1.20177.78%
1998-$0.43-35.71%
1997-$0.67-68.42%
1996-$2.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.73-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.60-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.65-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.63-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.01-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.11-91.49%๐Ÿ‡ซ๐Ÿ‡ท France